MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
contingent consideration...
$2,387M
(57.25%↑ Y/Y)
Amortization of intangible
assets
$1,748M
(-5.92%↓ Y/Y)
Proceeds from issuance of
long-term debt
$7,991M
(100.08%↑ Y/Y)
Acquired ipr&d and
milestones
$744M
(158.72%↑ Y/Y)
Net earnings
$697M
(-45.93%↓ Y/Y)
Stock-based compensation
$444M
(8.29%↑ Y/Y)
Depreciation
$188M
(3.87%↑ Y/Y)
Non-cash litigation
reserve adjustments,...
$150M
(120.58%↑ Y/Y)
Deferred income taxes
$137M
(589.29%↑ Y/Y)
Accounts receivable
-$87M
(-105.88%↓ Y/Y)
Other, net
$2M
(-93.55%↓ Y/Y)
Cash flows from
operating activities
$3,829M
(134.19%↑ Y/Y)
Cash flows from
financing activities
$919M
(173.05%↑ Y/Y)
Canceled cashflow
$2,753M
Canceled cashflow
$7,074M
Net change in cash
and equivalents
$4,162M
(1292.55%↑ Y/Y)
Canceled cashflow
$586M
Accounts payable and
other liabilities
-$1,594M
(-129.02%↓ Y/Y)
Payments of contingent
consideration liabilities
$722M
(31.51%↑ Y/Y)
Inventories
$184M
(18.71%↑ Y/Y)
Prepaid expenses and
other assets
$150M
(-76.11%↓ Y/Y)
Income tax assets and
liabilities, net
-$81M
(-121.43%↓ Y/Y)
Other, net
$22M
(229.41%↑ Y/Y)
Dividends paid
$3,086M
(5.50%↑ Y/Y)
Repayments of other
short-term borrowings
$2,000M
Purchases of treasury
stock
$1,489M
(54.94%↑ Y/Y)
Net change in
commercial paper...
-$499M
(-131.32%↓ Y/Y)
Cash flows from
investing activities
-$574M
(21.90%↑ Y/Y)
Effect of exchange rate
changes on cash and...
-$12M
(-233.33%↓ Y/Y)
Other acquisitions
and investments,...
$266M
(-20.36%↓ Y/Y)
Acquisitions of property and
equipment
$265M
(12.77%↑ Y/Y)
Other, net
$43M
(368.75%↑ Y/Y)
Back
Back
Cash Flow
ABBV_BIG copy-svg
AbbVie Inc. (ABBV)
ABBV_BIG copy-svg
AbbVie Inc. (ABBV)
source: myfinsight.com